Update – 2023 Best Price & Accumulator Adjustment Program Ruling

2023 was shaping up to be a year of challenging decisions for manufacturers and restricted access to critical pharmaceuticals for patients. The 2023 implementation of the proposed CMS Medicaid Best Price final rule change would have penalized drug manufacturers for offering patient assistance programs and coupon programs if manufacturers couldn’t guarantee that patients were receiving the full benefit of the program.

On May 17, 2022, The United States District Court for the District of Columbia vacated and set aside the Accumulator Adjustment Rule of 2020. Full details on the ruling can be found here.

“We agree with the District Court’s ruling and believe that this is a win for manufacturers and patients alike.”

– Patrick Patton, President

Subscribe to receive our publications.

Share this story, choose your platform.